BRAIN Biotech AG

Equities

BNN

DE0005203947

Real-time Estimate Tradegate Other stock markets 09:27:23 2026-01-20 am EST			5-day change	1st Jan Change
2.400 ^EUR	-0.83%		-10.82%	-5.16%

03:38am	BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026
Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI

Transcript : BRAIN Biotech AG - Analyst/Investor Day

Published on 12/12/2024 at 03:30 am EST

S&P Capital IQ

Presenter Speech
Adriaan Moelker (Executives)

Good morning, everyone, and welcome to the Capital Markets Day 2024 at BRAIN here in Zwingenberg. I see the slides are moving forward. It's a 5th Capital

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about BRAIN Biotech AG

03:38am	BRAIN Biotech AG, 2025 Earnings Call, Jan 14, 2026
Jan. 14	BRAIN Biotech AG Provides Revenue Guidance for the Year 2025/2026	CI
Jan. 13	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2025	CI
25-09-03	BRAIN Biotech AG Announces Executive Changes	CI
25-08-28	BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2025	CI
25-08-28	BRAIN Biotech AG Updates Sales Guidance for the Year 2025	CI
25-08-25	Corbion, BRAIN Biotech to Jointly Develop Biobased Antimicrobial Compounds	MT
25-08-25	Corbion and Brain Biotech Ag Team to Shape the Future of Innovation in Nature-Based Ingredient Technologies	CI
25-07-23	Brain Biotech Ag Appoints Ursula La Cognata as Member of Supervisory Board, Effective July 11, 2025	CI
25-05-28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI
25-05-20	Brain Biotech Takes Full Control of Dutch Unit Breatec, Plans New Continental Europe Hub	MT
25-05-20	BRAIN Biotech AG Announces Buy-Out of Minorities, New Continental European Production Site, and Expansion of Its Baking Application Center	CI
25-05-19	BRAIN Biotech AG acquired remaining minority stake in Breatec B.V.	CI
25-04-30	Brain Biotech Ag Updates Earnings Guidance for the Full Year 2025	CI
25-02-26	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2024	CI
25-02-13	BRAIN Biotech AG Collaborates with PX Group on the PX Urban Mining Initiative	CI
25-01-14	BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024	CI
24-12-12	BRAIN Biotech AG - Analyst/Investor Day
24-10-03	BRAIN Biotech AG Announces Resignation of Wiltrud Treffenfeldt as Member of the Supervisory Board	CI
24-09-23	Brain Biotech Signs EUR129 Million Royalty Deal for Hereditary Angioedema Treatment Compound	MT
24-08-29	BRAIN Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024	CI
24-05-28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
24-04-16	Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	MT
24-03-05	BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	CI
24-02-28	BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI